eMedicine Specialties > Neurology > Neurological Infections

Viral Meningitis: Differential Diagnoses & Workup

Author: Amir Vokshoor, MD, Staff Neurosurgeon, Department of Neurosurgery, Spine Surgeon, Diagnostic and Interventional Spinal Care, St John's Health Center
Coauthor(s): Cordia Wan, MD, Staff Neurologist, Beverly Hills Pain and Neurology Institute
Contributor Information and Disclosures

Updated: Oct 28, 2009

Differential Diagnoses

Abnormal Neonatal EEG
Low-Grade Astrocytoma
Acute Disseminated Encephalomyelitis
Lumbar Puncture (CSF Examination)
Aseptic Meningitis
Lyme Disease
Brucellosis
Migraine Variants
Cytomegalovirus Encephalitis
Neurocysticercosis
EEG in Status Epilepticus
Neurosarcoidosis
Haemophilus Meningitis
Neurosyphilis
Herpes Simplex Encephalitis
Staphylococcal Meningitis
HIV-1 Associated CNS Conditions: Meningitis
Subdural Empyema
HIV-1 Associated Opportunistic Infections: CNS
Systemic Lupus Erythematosus
HIV-1 Associated Opportunistic Infections: CNS Cryptococcosis
Tuberculous Meningitis
HIV-1 Associated Opportunistic Infections: CNS Toxoplasmosis
Varicella Zoster
Hydrocephalus
Leptomeningeal Carcinomatosis

Other Problems to Be Considered

Partially treated bacterial meningitis
Parameningeal infection
Coccidioides immitis infection
Cryptococcus neoformans infection
Histoplasma capsulatum infection
Candida species infection
Blastomyces dermatitidis infection
Mycoplasma infection
Listeria infection
Leptospira infection
Drugs
Heavy metals
Surgically implanted materials
Sjögren syndrome
Behçet disease
EEG in neurological infections

Workup

Laboratory Studies

  • Routine chemistry and hematology tests should be performed. 
    • In neonatal and severe cases, arterial blood gases analysis, coagulation studies, and liver function tests should also be considered.
    • Serum WBC count is not a sensitive indicator of the severity of infection, especially in the immunocompromised, neonatal, or elderly patient. 
    • Serum sodium level may be abnormal because of dehydration or the rare occurrence of syndrome of inappropriate antidiuretic hormone secretion (SIADH).
    • Serum amylase level may be elevated in cases caused by mumps even in the absence of parotitis.
    • Recent reports have shown high C-reactive protein (CRP) levels in the serum of children with bacterial meningitis whose CSF Gram stain findings were negative for bacteria; a comparable group of children with viral meningitis did not have similar elevations in serum CRP (ie, 50-150 in bacterial meningitis group vs <20 in viral meningitis group).
  • CSF examination is the most important test in differentiating the cause of meningitis. Prior to lumbar puncture (LP), a CT scan should be performed in patients with any abnormal neurological sign, to exclude an intracranial lesion or obstructive hydrocephalus. CSF culture remains the criterion standard in discerning bacterial or pyogenic from aseptic meningitis. Again, a partially treated bacterial meningitis may present with a negative Gram stain result and thus appear aseptic. The following are some CSF characteristics used to support the diagnosis of viral meningitis:
    • Cells: Pleocytosis with WBC counts in the range of 50 to >1000 x 109/L of blood has been reported in viral meningitis. Mononuclear cell predominance is the rule, but PMNs may comprise the majority of cells in the first 12-24 hours; the cell count usually is then dominated by lymphocytes in the classic CSF pattern of viral meningitis. This helps to distinguish viral from bacterial meningitis, which has a much higher cell count and a predominance of PMNs in the cell differential; this is by no means an absolute rule, however.
    • Protein: CSF protein level usually is only slightly elevated, but can range from being normal to as high as 200 mg/dL.
    • Glucose: Normal in most cases, but severe hypoglycorrhachia has been reported, especially with LCMV or mumps virus. Very low glucose levels with a lymphocytic pleocytosis may be seen in tuberculous meningitis.
    • Culture, Gram stain, and acid-fast stain: These tests should be performed, as well as polymerase chain reaction (PCR) testing for the likely viral pathogens in selected cases.
    • Antigens: CSF latex antigen testing helps to rule out bacterial causes such as Haemophilus influenzae and Neisseria meningitidis. Addition of a drop of CSF sediment to an India ink preparation may aid in the diagnosis of cryptococcal meningitis, although antigen assay testing for cryptococci is the preferred test.
    • Consider saving CSF for less common tests (ie, PCR for HIV and CMV) if the cause of meningitis is not certain after initial tests.
    • The exact sequence of testing for these agents depends on the clinical condition and suggestive facts in history and examination. For example, most cases of viral meningitis do not require PCR testing for HIV.
    • High WBC count in the CSF (especially neutrophils), high protein level, and low glucose level should suggest the diagnosis of a bacterial meningitis, although some viral pathogens may produce similar CSF profiles.
    • Real-time PCR testing for enterovirus was first cleared for marketing in 2007 by the FDA6 and is now available through commercial laboratories. Results are available in approximately 3 hours, as opposed to days to weeks in traditional PCR studies. In clearing the test, the FDA cited a multicenter study in which 96% of patients who tested positive did have viral meningitis, and 97% of patients who tested negative did not have viral meningitis. In a retrospective study of routine PCR testing of CSF for enterovirus—using a test with turnaround time of 23 hours—confirmation of enteroviral meningitis by PCR decreased the length of hospitalization and the duration of antibiotic use among infants 90 days of age or younger.7
    • In 2007, the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics published a Bacterial Meningitis Score that clinically predicts whether patients are at high or low risk for having bacterial meningitis versus aseptic meningitis.8  According to the score, patients have a very low risk for bacterial meningitis if all of the following are absent:
      • Positive CSF Gram stain
      • CSF absolute neutrophil count (ANC) of ≥1000
      • CSF protein of ≥80 mg/dL 
      • Peripheral ANC of ≥10,000 cells/mcL 
      • Seizure before or at time of presentation.
      • The higher number of criteria present, the higher the chance the patient has bacterial meningitis. 
      • This bacterial meningitis score may be used as an additional tool to aid in further management.
    • A retrospective multicenter study found that neither the presence nor quantity of immature neutrophils (bands) in CSF independently predicted bacterial meningitis among children with CSF pleocytosis.9

Imaging Studies

  • Imaging for suspected viral meningitis and encephalitis may include CT scan of the head with and without contrast, or MRI of the brain with gadolinium.
  • CT scan with contrast helps in ruling out intracranial pathology. Contrasted scans should be obtained to evaluate for any enhancement along the meninges and to exclude cerebritis, intracranial abscess, subdural empyema, or other lesions. Alternatively, and if readily available, an MRI of the brain with gadolinium may be performed.
  • MRI with contrast is the criterion standard in visualizing intracranial pathology in viral encephalitis (see Media file 1). HSV-1 commonly affects basal frontal and temporal lobes with a typical picture of diffusely enhancing bilateral lesions.

    T1-weighted MRI of brain demonstrates diffuse enh...

    T1-weighted MRI of brain demonstrates diffuse enhancement of the meninges in viral meningoencephalitis.

    T1-weighted MRI of brain demonstrates diffuse enh...

    T1-weighted MRI of brain demonstrates diffuse enhancement of the meninges in viral meningoencephalitis.

Other Tests

  • All patients whose condition is not improving clinically within 24-48 hours should have more extensive work-up to discern the cause of meningitis.
    • Blood, feces, and throat swabs may be sent for viral serology and cultures.
    • Acid-fast staining of CSF should be performed and the remaining fluid should be sent for PCR testing for HIV and CMV.
    • Serum titers of antibodies against HIV and toxoplasma should be obtained.
    • Additional serum collection 10-21 days later may aid in discerning rising titers in the antibodies against specific viral pathogens; a 4-fold increase in viral antibodies confirms the diagnosis. This is particularly useful for arboviral and LCMV cases, but also is helpful in ruling out toxoplasmosis, leptospirosis, borreliosis, and rickettsial infections. Although some of these studies do not yield an immediate result for clinical decision making, they may be useful for prognostication.
  • In case of suspected encephalitis, MRI with contrast enhancement and adequate visualization of the basal frontal and temporal areas is necessary.
  • EEG may be performed if encephalitis or subclinical seizures are suspected in the altered patient. Periodic lateralized epileptiform discharges (PLEDs) are often seen in herpetic encephalitis.

Procedures

  • Lumbar puncture is the most important procedure used in diagnosis of viral meningitis. Other potential procedures, depending on individual indications and disease severity, include intracranial pressure monitoring, brain biopsy, and ventricular drainage or shunting.
  • CT scan usually is performed prior to LP to rule out intracranial hematoma, mass effect, or obstructive hydrocephalus. The LP itself may provide significant symptomatic relief, presumably due to the decrease in intracranial pressure. LP should be performed in the standard sterile fashion, and the CSF opening pressure should be measured. Coagulopathy due to intrinsic or extrinsic factors (eg, warfarin) is a relative contraindication to LP. The clinician should exercise caution and, as for all medical procedures, weigh the risks and benefits associated with each individual case.
  • Intracranial pressure monitoring rarely is needed in patients with meningoencephalitis complicated by cerebral edema. The risks of intracranial hemorrhage in cases with coagulopathy often outweigh the diagnostic benefit of the monitor. The monitor should be placed under strictly sterile conditions by a neurosurgeon or neuro-intensivist.
  • Operative brain biopsy for confirmation of herpetic encephalitis largely has been replaced by PCR testing for viral DNA. In some cases, encephalomalacia due to an unknown viral infection may be confused with vascular infarction or rarely a tumor; a biopsy may be helpful. With the use of stereotactic localization and a needle biopsy, morbidity is minimal.

Histologic Findings

Because of the low mortality rate associated with acute viral meningitis, pathologic features other than lymphocytic response within the CSF are generally not in evidence. The leptomeninges undergo inflammation with PMNs and later mononuclear cells in the acute phase of the disease. Perivascular cuffing, neuronophagia, and increased number of microglial cells have been noted in specimens from patients who died of viral encephalitis.

More on Viral Meningitis

Overview: Viral Meningitis
Differential Diagnoses & Workup: Viral Meningitis
Treatment & Medication: Viral Meningitis
Follow-up: Viral Meningitis
Multimedia: Viral Meningitis
References

References

  1. CDC. Final 2008 West Nile Virus Activityin the United States. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount08_detailed.htm. Accessed September 1, 2009.

  2. Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. Mar 15 2008;371(9616):932-44. [Medline].

  3. INTERNATIONAL NOTEGLOBAL ADVISORY COMMITTEE ON VACCINE SAFETY, 11-12 JUNE, 2003. Canada Communicable Disease Report; April 1, 2004. [Full Text].

  4. Weekly Epidemiological Record. No. 3, 2007, 82. World Health Organization; January 19, 2007. 18-22. [Full Text].

  5. Landry ML, Greenwold J, Vikram HR. Herpes simplex type-2 meningitis: presentation and lack of standardized therapy. Am J Med. Jul 2009;122(7):688-91. [Medline].

  6. US Food and Drug Administration. FDA Clears Rapid Test for Meningitis. FDA. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108870.htm. Accessed September 1, 2009.

  7. King RL, Lorch SA, Cohen DM, Hodinka RL, Cohn KA, Shah SS. Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger. Pediatrics. Sep 2007;120(3):489-96. [Medline].

  8. Nigrovic, Kuppermann, Macias et al. Clinical Prediction Rule for Identifying Children With Cerebrospinal Fluid Pleocytosis at Very Low Risk of Bacterial Meningitis. JAMA. Jan 3, 2007;297:52-60. [Full Text].

  9. Kanegaye JT, Nigrovic LE, Malley R, Cannavino CR, Schwab SH, Bennett JE, et al. Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosis. Pediatrics. Jun 2009;123(6):e967-71. [Medline].

  10. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. Jul 2006;50(7):2409-14. [Medline][Full Text].

  11. Bobek MP, Sagher O. Aseptic meningitis caused by Teflon implantation for microvascular decompression. Case report. J Neurosurg. Jan 1999;90(1):145-7. [Medline].

  12. Cherry JD. Aseptic meningitis and viral meningitis. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 2. 4th ed. Philadelphia: Saunders; 1998:450-57.

  13. Doherty RL, Jordan MC. Viral meningoencephalitis. In: Infectious Diseases. 5th ed. 1994:1092-100.

  14. Eppes SC, Nelson DK, Lewis LL, Klein JD. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics. May 1999;103(5 Pt 1):957-60. [Medline].

  15. Hamilton MS, Jackson MA, Abel D. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J. Jun 1999;18(6):533-7. [Medline].

  16. Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. Sep 23 1999;341(13):936-42. [Medline].

  17. Ishii K, Kamei S, Takasu T. [Epidemiology of virus-related nervous infections in Japan]. Nippon Rinsho. Apr 1997;55(4):839-48. [Medline].

  18. Karande S, Patil S, Kulkarni M. Acute aseptic meningitis as the only presenting feature of leptospirosis. Pediatr Infect Dis J. Apr 2005;24(4):390-1. [Medline].

  19. Mohle-Boetani JC, Matkin C, Pallansch M, et al. Viral meningitis in child care center staff and parents: an outbreak of echovirus 30 infections. Public Health Rep. May-Jun 1999;114(3):249-56. [Medline].

  20. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med. Jun 14 1999;159(11):1185-94. [Medline].

  21. Muir P, Kammerer U, Korn K. Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev. Jan 1998;11(1):202-27. [Medline].

  22. Norris CM, Danis PG, Gardner TD. Aseptic meningitis in the newborn and young infant. Am Fam Physician. May 15 1999;59(10):2761-70. [Medline].

  23. Oostenbrink R, Moll HA, Moons KG. Predictive model for childhood meningitis. Pediatr Infect Dis J. Nov 2004;23(11):1070-1. [Medline].

  24. Powell S, Schochet SS. Selected pediatric viral infections. Semin Pediatr Neurol. Sep 1995;2(3):211-9. [Medline].

  25. Pérez-Vélez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. Oct 15 2007;45(8):950-7. [Medline].

  26. Rotbart HA. Viral meningitis and the aseptic meningitis syndrome. In: Lambert HP, ed. Infections of the Central Nervous System. Philadelphia: Decker; 1991:19-39.

  27. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J. Dec 1999;18(12):1033-9; quiz 1040. [Medline].

  28. Sormunen P, Kallio MJ, Kilpi T, Peltola H. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr. Jun 1999;134(6):725-9. [Medline].

  29. Takeoka T. [Cerebrospinal fluid examination in the infectious meningitis and encephalitis]. Nippon Rinsho. Apr 1997;55(4):809-14. [Medline].

  30. Waisman Y, Lotem Y, Hemmo M, et al. Management of children with aseptic meningitis in the emergency department. Pediatr Emerg Care. Oct 1999;15(5):314-7. [Medline].

Further Reading

Keywords

aseptic meningitis, serous meningitis, nonpyogenic leptomeningitis, abacterial meningitis, enterovirus, coxsackievirus, echovirus, viral meningitis, viral infection, herpes viruses, HSV-1, HSV-2, varicella zoster virus, VZV, B virus

Contributor Information and Disclosures

Author

Amir Vokshoor, MD, Staff Neurosurgeon, Department of Neurosurgery, Spine Surgeon, Diagnostic and Interventional Spinal Care, St John's Health Center
Amir Vokshoor, MD is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, American Medical Association, and North American Spine Society
Disclosure: Nothing to disclose.

Coauthor(s)

Cordia Wan, MD, Staff Neurologist, Beverly Hills Pain and Neurology Institute
Cordia Wan, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Medical Editor

J Stephen Huff, MD, Associate Professor, Emergency Medicine and Neurology, Department of Emergency Medicine, University of Virginia Health Sciences Center
J Stephen Huff, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Neurology, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed is a member of the following medical societies: American Academy of Neurology, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.